Skip to content
healthcare.dev

Tresiba

NDC 0169-2662, insulin degludec, injection, solution, from Novo Nordisk.

Product NDC
0169-2662
Status
Listed
Labeler
Novo Nordisk
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA203314
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2662 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN DEGLUDEC100 U/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0169-2662-11001692662111 VIAL, GLASS in 1 CARTON (0169-2662-11) / 10 mL in 1 VIAL, GLASS
0169-2662-90001692662901 VIAL, GLASS in 1 CARTON (0169-2662-90) / 10 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/456c5e87-3dfd-46fa-8ac0-c6128d4c97c6
  • NADAC price for package 00169266211

    GET /v1/drugs/nadac/00169266211

Use it

Look up 0169-2662 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2662 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-2662. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.